P1124: MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA
- DOI
- 10.1097/01.hs9.0000847364.49527.45
- Published
- 2022-06
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/01.hs9.0000847364.49527.45,
title = {P1124: MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA},
author = {C. Y. Cheah and N. L. Bartlett and S. Assouline and S. J. Schuster and W. Seog Kim and M. Shadman and I. Isufi and S. Yin and M. Y. Doral and J. Sit and V. Chen and H. Huang and M. Zhou and M. C. Wei and L. E. Budde},
year = {2022},
journal = {HemaSphere},
doi = {10.1097/01.hs9.0000847364.49527.45},
url = {https://doi.org/10.1097/01.hs9.0000847364.49527.45}
}RIS
TY - JOUR TI - P1124: MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA AU - C. Y. Cheah AU - N. L. Bartlett AU - S. Assouline AU - S. J. Schuster AU - W. Seog Kim AU - M. Shadman AU - I. Isufi AU - S. Yin AU - M. Y. Doral AU - J. Sit AU - V. Chen AU - H. Huang AU - M. Zhou AU - M. C. Wei AU - L. E. Budde PY - 2022 JO - HemaSphere DO - 10.1097/01.hs9.0000847364.49527.45 UR - https://doi.org/10.1097/01.hs9.0000847364.49527.45 ER -
APA
Cheah, C. Y., Bartlett, N. L., Assouline, S., Schuster, S. J., Kim, W. S., Shadman, M., Isufi, I., Yin, S., Doral, M. Y., Sit, J., Chen, V., Huang, H., Zhou, M., Wei, M. C., & Budde, L. E. (2022). P1124: MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA. HemaSphere. https://doi.org/10.1097/01.hs9.0000847364.49527.45
Source records
- crossref · retrieved 2026-09-26T00:42:09.659Z